Related Experiment Video
Updated: Apr 19, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Association of a pre-miR-27a polymorphism with cancer risk: an updated meta-analysis
Rong-Pan Bai1, Yu Weng, Li-Ling Su
1Institute of Environmental Health, Zhejiang Univerisity School of Medicine, Hangzhou, China E-mail : chenguangdi@gmail.com or llq199@yahoo.com.cn.
Abstract:
MicroRNA-27a is highly expressed in cancers and has been identified as an oncogenic microRNA. A genetic variant in pre-miR-27a (rs895819) with a transition of A to G has been demonstrated to be associated with cancer risk; however, the results of these studies remain conflicting rather than conclusive. Therefore, we performed a meta-analysis to derive a more precise estimation. Through searching PubMed or other databases up to March 2014 using the following MeSH terms and keywords, "miR-27a", "polymorphism" and "cancer", seventeen case-control studies were identified in this meta-analysis, including 7,813 cases and 9,602. Crude odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were calculated to investigate the association strength between rs895819 and the susceptibility of cancer. The results of the overall meta-analysis did not suggest any association between rs895819 polymorphism and cancer susceptibility, and this remained in Asians as a sub- group. In Caucasians, however, the rs895819 was associated with a reduced cancer risk in heterozygous (OR, 0.83; 95%CI, 0.75-0.93) and dominant models (OR, 0.84; 95%CI, 0.76-0.93), and the [G] allele of rs895819 showed a protective effect (OR, 0.90, 95%CI, 0.84-0.97). Further studies showed a significant association between the [G] allele of rs895819 and decreased risk of breast cancer (0.91; 95%CI, 0.85-0.98), and stratified analyses indicated a protective effect of the [G] allele in Caucasians (OR, 0.89; 95%CI, 0.82-0.98), younger breast cancer cases (OR, 0.87; 95%CI, 0.79-0.96), and in the group of unilateral breast cancer patients (OR, 0.90; 95%CI, 0.83-0.97). These findings suggest an association between pre-miR-27a polymorphism rs895819 and cancer risk in Caucasians. The protective effect of rs895819 [G] allele in younger breast cancer and in the group of unilateral breast cancer patients await further confirmation since the included studies in this meta-analysis were limited.
Insights
This meta-analysis found no overall association between the pre-microRNA-27a (miR-27a) rs895819 genetic variant and cancer risk. However, the G allele of this polymorphism showed a protective effect against cancer in Caucasians, particularly in breast cancer cases.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- MicroRNA-27a (miR-27a) is an oncogenic microRNA frequently overexpressed in various cancers.
- A known genetic variant in pre-miR-27a, rs895819 (A>G), has been investigated for its association with cancer risk, but existing study results are conflicting.
Purpose of the Study:
- To conduct a meta-analysis to clarify the association between the pre-miR-27a rs895819 polymorphism and cancer susceptibility.
- To provide a more precise estimation of the risk conferred by this genetic variant.
Main Methods:
- A comprehensive literature search was performed in PubMed and other databases up to March 2014.
- Seventeen case-control studies comprising 7,813 cancer cases and 9,602 controls were included in the meta-analysis.
- Crude odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to assess the association between rs895819 and cancer risk.
Main Results:
- The overall meta-analysis revealed no significant association between the rs895819 polymorphism and overall cancer susceptibility, including in Asian populations.
- In Caucasian populations, the rs895819 polymorphism was associated with a reduced cancer risk under heterozygous and dominant models.
- The G allele of rs895819 demonstrated a protective effect against cancer in Caucasians (OR, 0.90; 95% CI, 0.84-0.97), with a significant association observed for decreased breast cancer risk (OR, 0.91; 95% CI, 0.85-0.98).
Conclusions:
- The pre-miR-27a rs895819 polymorphism is associated with cancer risk in Caucasian populations.
- The G allele of rs895819 exhibits a protective effect, particularly in breast cancer, younger patients, and unilateral cases, though further confirmation is needed due to study limitations.
Related Concept Videos
Cancer Prevention
Some...
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
lncRNA - Long Non-coding RNAs

